• 1 July, 2014
  • Dr. Meshorer grew up in a household that included both science and art, and he continues to be active in and out of the lab. You'll never guess where he accepted a position as a producer before he became a principal investigator. Discover that and more in this month’s Member Spotlight.
    Full story
  • 12 June, 2014
  • The International Society for Stem Cell Research (ISSCR) is pleased to announce Rudolf Jaenisch, Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology (MIT), as incoming president of the ISSCR board of directors, immediately following the ISSCR’s 12th Annual Meeting, June 18-21, 2014. Jaenisch will serve as president for one year and succeeds Janet Rossant. The role of vice president will be filled by Sally Temple, Neural Stem Cell Institute.
    Full story
  • 30 May, 2014
  • The ISSCR welcomes the recent EU Commission’s response to concerns about how funding from the Horizon 2020 EU Research and Innovation program is to be used for human embryonic stem cell research. The ISSCR advocates that all forms of stem cell research are crucial for the advancement of our understanding of human health and disease and for the development of novel treatments.
    Full story
  • 1 April, 2014
  • What unusual profession helped Dr. Ludwig pay for two years of school? How did she become director of the WiCell Stem Cell Bank and not an IVF clinic as she envisioned? Find out in this month's Member Spotlight.
    Full story
  • Two Papers Open a New Window into Pluripotency

    1/29/2014 6:00:00 AM

    The ISSCR is pleased to help spread the news about two papers published online today in Nature that describe the induction of pluripotency in cells from a newborn mouse without the use of extrinsic transcription factors, chemical manipulation or nuclear transfer.
    Full story
  • ISSCR Statement of Delivery of Unproven Autologous Cell-based Interventions to Patients

  • 12 September, 2013
  • The International Society for Stem Cell Research (ISSCR) urges medical licensing bodies, legal authorities, patient advocacy organizations, physicians, and others to exercise their influence to discourage commercial provision of unproven autologous cell-based interventions outside of clinical trials.
    Full story
  • Read the ISSCR 11th Annual Meeting Recap

  • 11 July, 2013
  • Full story
  • ISSCR Celebrates Inaugural Issue of its Open Access Journal, Stem Cell Reports

  • 4 June, 2013
  • 6/4/2013 5:00:00 AM

    The International Society for Stem Cell Research (ISSCR) is excited to announce the inaugural issue of Stem Cell Reports, the society’s new open-access journal, published today. Stem Cell Reports, published for the ISSCR by Cell Press, presents high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine, with a focus on shorter, single-point articles.
    Full story
  • ISSCR Emphasizes Importance of Regulatory Oversight for Stem Cell Products for Clinical Use

  • 22 April, 2013
  • The ISSCR urges Italian lawmakers to heed concerns of scientists around the world about the premature practice of unproven stem cell treatments and to recognize the importance of regulatory oversight and patient protection when developing new stem cell medicines.
    Full story
  • ISSCR Voices Concern as Italian Government Authorizes Unproven Stem Cell Therapy

  • 9 April, 2013
  • The International Society for Stem Cell Research (ISSCR) voices concern as the Italian government authorizes an unproven stem cell therapy for use in patients.
    Full story
  • ISSCR President, Board Member, and 11th Annual Meeting Keynote Speaker Among Winners of Breakthrough Prize

  • 20 February, 2013
  • ISSCR President, Shinya Yamanaka, Board of Directors member Hans Clevers and the ISSCR 2013 Annual Meeting Keynote Speaker Eric Lander, were three of 11 distinguished recipients of the inaugural Breakthrough Prize in Life Sciences, announced today
    Full story
  • ISSCR Reaffirms Support for All Forms of Stem Cell Research

  • 11 October, 2012
  • The ISSCR further congratulates Drs. Shinya Yamanaka and John Gurdon for their scientific achievements recognized by this year's Nobel Prize and reaffirms support for all forms of stem cell research.
    Full story
  • The ISSCR Congratulates Yamanaka and Gurdon on Nobel Prize

  • 8 October, 2012
  • The International Society for Stem Cell Research (ISSCR) congratulates its 2011 McEwen Award recipient and current president Shinya Yamanaka, and fellow stem cell pioneer, Sir John Gurdon, on winning the Nobel Prize for Physiology or Medicine, announced today.
    Full story
  • ISSCR Emphasizes Rigorous Oversight for Application of Stem Cell-Based Treatments

  • 12 April, 2012
  • The ISSCR is concerned that some stem cell treatments are being prematurely offered to patients without safeguards in place to ensure safety and efficacy.
    Full story
  • ISSCR Honors Stem Cell Research Pioneer with Prestigious McEwen Award for Innovation

  • 23 February, 2012
  • The ISSCR is pleased to announce the winner of the 2012 McEwen Award for Innovation, a coveted prize in the field of stem cell research and regenerative medicine. The 2012 recipient is Rudolf Jaenisch, MD, Founding Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology
    Full story
  • ISSCR Decries Negative Impact of Stem Cell Injunction on Science and Medicine

  • 12 September, 2010
  • Vital progress in stem cell research by hundreds of U.S. laboratories is threatened after last week’s injunction prohibiting federal funding for the study of human embryonic stem cells (hESCs).
    Full story
  • Tumors After Attempted Stem Cell Therapy Highlight Importance of Rigorous Standards Before Clinical Treatment

  • 4 March, 2009
  • 3/4/2009 6:00:00 AM

    The ISSCR is concerned and saddened by the recent report of nervous system tumors that developed in a child who had previously received injections of cell preparations referred to as “neural stem cells.” This illustrates the concerns that prompted the ISSCR to develop Guidelines for the Clinical Translation of Stem Cells, released in December 2008.
    Full story
  • ISSCR Scientists Elated for Future of Human Embryonic Stem Cell Research After Obama Lifts Funding Ban

  • 3 March, 2009
  • The ISSCR applauds President Barack Obama’s decision to expand federal funding for human embryonic stem cell research by rescinding the policy of Aug. 9, 2001, which restricted federally-funded researchers to using only the small number of cell lines created before that date.
    Full story
  • Weissman, Yamanaka and Schöler Receive Prestigious Award from German Scientific Foundation

  • 14 November, 2008
  • In a ceremony today ISSCR President-Elect Irving L. Weissman (USA), Board Member Shinya Yamanaka (Japan) and Member Hans Schöler (Germany) were awarded the prestigious Robert Koch Prize by the Robert Koch Foundation. The International Society for Stem Cell Research congratulates them for earning this honor.
    Full story
  • Scientists Urge President-Elect Obama to Restore U.S. Funding of Stem Cell Research

  • 6 November, 2008
  • The ISSCR, representing the world’s leading stem cell scientists, urges President-Elect Barack Obama to restore federal funding for embryonic stem cell research in the first 100 days of his presidency.
    Full story
    View All ISSCR News